ATRA
Atara Biotherapeutics Inc
8.50$
-0.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
Atara Biotherapeutics Inc (ATRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -3.3 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -51 | -50 | -30 | -11 | -4.0 | -24 | -28 | -7.3 | -9.8 | -5.7 | -3.1 | -3.3 | -22 | |
| 1.2 | 1.2 | 1.4 | 1.3 | 1.2 | 1.1 | 1.8 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 11 | 9.9 | 8.4 | 6.3 | 6.4 | 5.8 | 4.2 | 2.8 | 1.2 | 1.5 | 0.7 | 0.4 | 3.9 | |
| 2.0 | -7.3 | -12 | -3.4 | 6.6 | -22 | -82 | -13 | -7.9 | -2.0 | -0.8 | 0.7 | -9.9 | |
| 0.3 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 70 | 9.9 | 15 | 7.2 | -17 | 3.4 | 17 | -5.1 | -2.4 | 8.4 | – | -6.6 | – | |
| – | 0.1 | 0.0 | – | 0.0 | 0.0 | – | – | – | – | – | – | – | |
| – | – | – | – | -0.2 | -0.2 | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -0.2 | 1.5 | 24 | -0.3 | 36 | -0.3 | -0.3 | 15 | 1.0 | 0.0 | 3.0 | 4.8 | 8.8 | |
| 19 | -39 | 9.2 | -3.8 | 15 | -21 | -11 | 2.9 | -11 | 2.7 | -0.1 | -5.1 | -14 | |
| -52 | -50 | -30 | -11 | -4.0 | -25 | -28 | -7.3 | -9.8 | -5.7 | -3.1 | -3.3 | -22 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.